Sotio Česky English По русски 舒迪安中国 SOTIO is a biotechnology company developing a next generation Active Cellular Immunotherapy based on activated dendritic cells for the treatment of cancer and autoimmune diseases. SOTIO continues to develop new therapies to address unmet medical needs using its immunotherapy platform and proprietary cell-based technologies. Active Cellular Immunotherapy focusing on the treatment of cancer diseases Learn more about >> Job Opportunities The company is looking for talented, motivated, dynamic employees to join its international team, who will have the opportunity to utilize and further develop their own abilities. SOTIO exhibits at ESMO 2014 SOTIO, the biotechnology company owned by PPF Group, is presenting its clinical research program at the European Society for Medical ABOUT US RESEARCH MANUFACTURING CLINICAL TRIALS NEWS CONTACTS SOTIO Medical Research (Beijing) Co., Ltd. Beijing Economic-Technological Dev. Area 99 Kechuang 14, 30-B Beijing,China (map) SOTIO LLC Pravdy Street, 8/1, Moscow Russia (map) SOTIO, LLC 180 Canal St., Suite 300, Boston, MA, USA (map) SOTIO a.s. Jankovcova 1518/2, Prague Czech Republic (map) About this site Sitemap Send mail MEMBER OF PPF GROUP